When you enter multiple keywords separated by space, your search will contain results that match any of the keywords (OR search).
  • 12 Hits
  • Search Condition : Filter (MeSH = Small Cell Lung Carcinoma / pathology)
Species Resource Title
Human and Animal Cells A549 Notch1 signaling controls cell proliferation, apoptosis and differentiation in lung carcinoma.
Human and Animal Cells LC-2/ad(RCB0440) HADHA is a potential predictor of response to platinum-based chemotherapy for lung cancer.
Human and Animal Cells MBT-2(RCB0544) Combination Treatment of the Oral CHK1 Inhibitor, SRA737, and Low-Dose Gemcitabine Enhances the Effect of Programmed Death Ligand 1 Blockade by Modulating the Immune Microenvironment in SCLC.
DNA material pENTR4-H1 (RDB04395) , CS-RfA-CG (RDB04390) CADM1 promotes malignant features of small-cell lung cancer by recruiting 4.1R to the plasma membrane.
Human and Animal Cells Lu-134-A(RCB0466) , Lu-134-B(RCB0467) , Lu-139(RCB0469) An integrative transcriptome analysis reveals a functional role for thyroid transcription factor-1 in small cell lung cancer.
Human and Animal Cells Lu-165(RCB1184) MYCL is a target of a BET bromodomain inhibitor, JQ1, on growth suppression efficacy in small cell lung cancer cells.
Human and Animal Cells PC-9(RCB4455) Class III/IV POU transcription factors expressed in small cell lung cancer cells are involved in proneural/neuroendocrine differentiation.
Human and Animal Cells Long noncoding RNA HOTAIR is relevant to cellular proliferation, invasiveness, and clinical relapse in small-cell lung cancer.
Human and Animal Cells A549(RCB0098) Size-based isolation of circulating tumor cells in lung cancer patients using a microcavity array system.
Human and Animal Cells POU domain transcription factor BRN2 is crucial for expression of ASCL1, ND1 and neuroendocrine marker molecules and cell growth in small cell lung cancer.
Human and Animal Cells Detection of tumor-specific autoantibodies in sera of patients with lung cancer.
Human and Animal Cells MS-1(RCB0725) , Lu-139(RCB0469) Control of the MYC-eIF4E axis plus mTOR inhibitor treatment in small cell lung cancer.